{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-067081","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2026-06-10T11:30:39+00:00","discovered_at":"2026-06-10T11:35:00.291931+00:00","generated_at":"2026-06-10T11:35:12.930727+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Incannex receives A$6M R&D tax refund; expects another A$5.1M in 2026","bullets":["Received A$6,039,162 under Australian Government's R&D Tax Incentive Program for FY25.","Expects additional ~A$5.1M later in 2026, total >A$11.1M non-dilutive capital received this year.","Non-dilutive refund strengthens balance sheet, supports clinical programs (IHL-42X, PSX-001) and share repurchase.","CEO states refund obtained without issuing shares; company remains debt-free."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-067081","json":"https://secwatch.observer/filing/0001213900-26-067081.json","markdown":"https://secwatch.observer/filing/0001213900-26-067081.md","text":"https://secwatch.observer/filing/0001213900-26-067081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026067081/0001213900-26-067081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026067081/ea0293917-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T11:35:12.930727+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}